A - Trademark Details
Status: 734 - Fifth Extension - Granted
Serial Number
87927618
Word Mark
A
Status
734 - Fifth Extension - Granted
Status Date
2021-09-15
Filing Date
2018-05-18
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Typeset
Published for Opposition Date
2019-02-12
Attorney Name
Law Office Assigned Location Code
M10
Employee Name
VOHRA, SANJEEV KUMAR
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of a stylized letter "A".
Goods and Services
Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of ocular diseases; pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of ocular diseases
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-05-26
Primary Code
005
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Ann Lamport Hammitte
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2018-05-22 | NEW APPLICATION ENTERED IN TRAM |
| 2018-05-26 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2018-06-11 | ASSIGNED TO EXAMINER |
| 2018-06-19 | NON-FINAL ACTION WRITTEN |
| 2018-06-19 | NON-FINAL ACTION E-MAILED |
| 2018-06-19 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2018-12-12 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2018-12-12 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2018-12-12 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2018-12-13 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2019-01-07 | ASSIGNED TO LIE |
| 2019-01-23 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2019-02-12 | PUBLISHED FOR OPPOSITION |
| 2019-02-12 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2019-04-09 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2019-10-09 | TEAS EXTENSION RECEIVED |
| 2019-10-09 | EXTENSION 1 FILED |
| 2019-10-09 | EXTENSION 1 GRANTED |
| 2019-10-11 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-03-30 | TEAS EXTENSION RECEIVED |
| 2020-03-30 | EXTENSION 2 FILED |
| 2020-03-30 | EXTENSION 2 GRANTED |
| 2020-04-01 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-10-07 | TEAS EXTENSION RECEIVED |
| 2020-10-07 | EXTENSION 3 FILED |
| 2020-10-07 | EXTENSION 3 GRANTED |
| 2020-10-09 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2021-04-09 | TEAS EXTENSION RECEIVED |
| 2021-04-09 | EXTENSION 4 FILED |
| 2021-04-09 | EXTENSION 4 GRANTED |
| 2021-04-13 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2021-09-09 | TEAS EXTENSION RECEIVED |
| 2021-09-15 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2021-09-09 | EXTENSION 5 FILED |
| 2021-09-15 | EXTENSION 5 GRANTED |
| 2021-09-16 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
